Pyramidal cell responses to γ‐aminobutyric acid differ in type I and type II cortical dysplasia

Abnormalities in the γ‐aminobutyric acid (GABA)‐ergic system could be responsible for seizures in cortical dysplasia (CD). We examined responses of pyramidal neurons to exogenous application of GABA, as well as alterations of GABAergic interneuron number and size in pediatric epilepsy surgery patients with non‐CD, type I CD, and type II CD pathologies. We used the dissociated cell preparation for electrophysiology along with immunohistochemistry to identify number and size of GABAergic cells. Pyramidal neurons from type I CD tissue showed increased EC50 and faster kinetics compared with cells from non‐CD and type II CD tissue. Cytomegalic pyramidal neurons showed increased GABA peak currents and decreased peak current densities, longer kinetics, and decreased sensitivity to zolpidem and zinc compared with normal pyramidal cells from non‐CD and type I CD. There were fewer but larger glutamic acid decarboxylase (GAD)‐containing cells in type II CD tissue with cytomegalic neurons compared with non‐CD, type I CD, and type II CD without cytomegalic neurons. In addition, GABA transporters (VGAT and GAT‐1) showed increased staining surrounding cytomegalic neurons in type II CD tissue. These results indicate that there are differences in GABAA receptor‐mediated pyramidal cell responses in type I and type II CD. Alterations in zolpidem and zinc sensitivities also suggest that cytomegalic neurons have altered GABAA receptor subunit composition. These findings support the hypothesis that patients with type I and type II CD will respond differently to GABA‐mediated antiepileptic drugs and that cytomegalic neurons have features similar to immature neurons with prolonged GABAA receptor open channel times. © 2008 Wiley‐Liss, Inc.

[1]  Gary W. Mathern,et al.  Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis , 2006, Epilepsy & Behavior.

[2]  A. Kriegstein,et al.  Changing properties of GABA(A) receptor-mediated signaling during early neocortical development. , 1999, Journal of neurophysiology.

[3]  A. Kriegstein,et al.  An excitatory GABAergic plexus in developing neocortical layer 1. , 2000, Journal of neurophysiology.

[4]  C. Cepeda,et al.  NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. , 2004, Cerebral cortex.

[5]  L. Martinian,et al.  Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis , 2003, Acta Neuropathologica.

[6]  H. Vinters,et al.  Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study , 2004, Acta Neuropathologica.

[7]  D. Coulter,et al.  Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy , 1998, Nature Medicine.

[8]  R. Macdonald,et al.  GABA(A) receptor function and pharmacology in epilepsy and status epilepticus. , 2003, Current opinion in pharmacology.

[9]  Arnold R. Kriegstein,et al.  Is there more to gaba than synaptic inhibition? , 2002, Nature Reviews Neuroscience.

[10]  L Tassi,et al.  Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. , 2002, Brain : a journal of neurology.

[11]  A. Palmini,et al.  Terminology and classification of the cortical dysplasias , 2004, Neurology.

[12]  C. Cepeda,et al.  Human cortical dysplasia and epilepsy: an ontogenetic hypothesis based on volumetric MRI and NeuN neuronal density and size measurements. , 2004, Cerebral cortex.

[13]  A. Aguzzi,et al.  Selective Alterations in GABAA Receptor Subtypes in Human Temporal Lobe Epilepsy , 2000, The Journal of Neuroscience.

[14]  J. Pretorius,et al.  Glutamate decarboxylase-immunoreactive neurons are preserved in human epileptic hippocampus , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  M. Hildebrandt,et al.  Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies , 2005, Acta Neuropathologica.

[16]  P. Mischel,et al.  Cerebral Cortical Dysplasia Associated with Pediatric Epilepsy. Review of Neuropathologic Features and Proposal for a Grading System , 1995, Journal of neuropathology and experimental neurology.

[17]  G. Jackson,et al.  Clinical and imaging features of cortical malformations in childhood , 1999, Neurology.

[18]  J. Trojanowski,et al.  Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity , 1997, Acta Neuropathologica.

[19]  E. Benardete,et al.  Increased Excitability and Decreased Sensitivity to GABA in an Animal Model of Dysplastic Cortex , 2002, Epilepsia.

[20]  P. Krsek,et al.  Densities of parvalbumin-immunoreactive neurons in non-malformed hippocampal sclerosis-temporal neocortex and in cortical dysplasias , 2006, Brain Research Bulletin.

[21]  E. R. Whittemore,et al.  Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes. , 1996, Molecular pharmacology.

[22]  T. Freund,et al.  gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Czajkowski,et al.  Identification of benzodiazepine binding site residues in the gamma2 subunit of the gamma-aminobutyric acid(A) receptor. , 2000, Molecular pharmacology.

[24]  M. Tohyama,et al.  GABAA Receptor subunit messenger RNAs show differential expression during cortical development in the rat brain , 1992, Neuroscience.

[25]  C. Cepeda,et al.  Pediatric Cortical Dysplasia: Correlations between Neuroimaging, Electrophysiology and Location of Cytomegalic Neurons and Balloon Cells and Glutamate/GABA Synaptic Circuits , 2005, Developmental Neuroscience.

[26]  G. Biggio,et al.  Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. , 2002, European journal of pharmacology.

[27]  C. Cepeda,et al.  Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia , 2003, Journal of neuroscience research.

[28]  C. Cepeda,et al.  Are Cytomegalic Neurons and Balloon Cells Generators of Epileptic Activity in Pediatric Cortical Dysplasia? , 2005, Epilepsia.

[29]  A. Leslie Morrow,et al.  GABAA Receptor α1 Subunit Deletion Prevents Developmental Changes of Inhibitory Synaptic Currents in Cerebellar Neurons , 2001, The Journal of Neuroscience.

[30]  M. Phelps,et al.  Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment , 1990, Annals of neurology.

[31]  C. Cepeda,et al.  Cytomegalic Interneurons: A New Abnormal Cell Type in Severe Pediatric Cortical Dysplasia , 2007, Journal of neuropathology and experimental neurology.

[32]  M. Calcagnotto,et al.  Dysfunction of Synaptic Inhibition in Epilepsy Associated with Focal Cortical Dysplasia , 2005, The Journal of Neuroscience.

[33]  R. Garbelli,et al.  Inhibitory Circuits in Human Dysplastic Tissue , 2000, Epilepsia.

[34]  S. Roper,et al.  The GABAergic System of the Developing Neocortex Has a Reduced Capacity to Recover from In Utero Injury in Experimental Cortical Dysplasia , 2004, Journal of neuropathology and experimental neurology.

[35]  T. Freund,et al.  Impaired and repaired inhibitory circuits in the epileptic human hippocampus , 2005, Trends in Neurosciences.

[36]  Germán Sierra-Paredes,et al.  Extrasynaptic GABA and glutamate receptors in epilepsy. , 2007, CNS & neurological disorders drug targets.

[37]  K. Gingrich,et al.  Zn2+ inhibition of recombinant GABAA receptors: an allosteric, state‐dependent mechanism determined by the γ‐subunit , 1998, The Journal of physiology.

[38]  M A Falconer,et al.  Focal dysplasia of the cerebral cortex in epilepsy , 1971, Journal of neurology, neurosurgery, and psychiatry.

[39]  J. Hablitz,et al.  Altered Receptor Subunit Expression in Rat Neocortical Malformations , 2000, Epilepsia.

[40]  J. DeFelipe,et al.  Microanatomy of the dysplastic neocortex from epileptic patients. , 2004, Brain : a journal of neurology.

[41]  J. DeFelipe.  Chandelier cells and epilepsy. , 1999, Brain : a journal of neurology.

[42]  C. Czajkowski,et al.  Molecular dissection of benzodiazepine binding and allosteric coupling using chimeric gamma-aminobutyric acidA receptor subunits. , 1998, Molecular pharmacology.

[43]  Wei-Yang Lu,et al.  Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy , 2002, Nature Genetics.

[44]  O W Witte,et al.  Differential Downregulation of GABAA Receptor Subunits in Widespread Brain Regions in the Freeze-Lesion Model of Focal Cortical Malformations , 2000, The Journal of Neuroscience.

[45]  J. DeFelipe,et al.  Chandelier cell axons are immunoreactive for GAT‐1 in the human neocortex , 1998, Neuroreport.

[46]  M. Avoli,et al.  GABAA receptor-dependent synchronization leads to ictogenesis in the human dysplastic cortex. , 2004, Brain : a journal of neurology.

[47]  M. Nieto Barrera.  [Infantile spasms]. , 1990, Anales espanoles de pediatria.

[48]  G. Klem,et al.  Epileptogenicity of Focal Malformations Due to Abnormal Cortical Development: Direct Electrocorticographic–Histopathologic Correlations , 2003, Epilepsia.

[49]  Yufei Wang,et al.  Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2. , 1996, Molecular pharmacology.

[50]  G. Mathern,et al.  Postoperative Seizure Control and Antiepileptic Drug Use in Pediatric Epilepsy Surgery Patients: The UCLA Experience, 1986–1997 , 1999, Epilepsia.

[51]  B. Hutcheon,et al.  Organization of GABAA receptor α‐subunit clustering in the developing rat neocortex and hippocampus , 2004, The European journal of neuroscience.